DepilloLisa's profile picture. Working for Heart Failure Awareness and loving life

Lisa DePillo

@DepilloLisa

Working for Heart Failure Awareness and loving life

Lisa DePillo reposted

Really nice piece on device therapy in HF complicated by cardiorenal perturbations! An intersection between the heart and kidney that is ripe for investigation and innovation! @preventfailure @HFHCardioFellow @NavinKapur4 @JHMontfort10 @FudimMarat

In this JCF Ignite 🔥 piece, the authors explore novel interventions aimed at treating cardiorenal syndrome & achieving decongestion: ❓Which patients will benefit from renal pushers vs puller devices? ❓How do we measure success w/ these novel devices? 🔗bit.ly/4hHHKYn

JCardFail's tweet image. In this JCF Ignite 🔥 piece, the authors explore novel interventions aimed at treating cardiorenal syndrome & achieving decongestion:
❓Which patients will benefit from renal pushers vs puller devices?
❓How do we measure success w/ these novel devices? 
🔗bit.ly/4hHHKYn


Lisa DePillo reposted

VAD coordinators are the heartbeat of the advanced #HeartFailure care team, ensuring patients receive the support they need to thrive. Join us in celebrating their tireless dedication & thank an #LVAD coordinator today. US Safety Info: bit.ly/4e89frw

AbbottCardio's tweet image. VAD coordinators are the heartbeat of the advanced #HeartFailure care team, ensuring patients receive the support they need to thrive.

Join us in celebrating their tireless dedication & thank an #LVAD coordinator today.

US Safety Info: bit.ly/4e89frw

Lisa DePillo reposted

Dennis doesn’t let #HeartFailure keep him from being a hands-on dad. Watch his story to see how our #HeartMate3 LVAD helps him show up (and keep up) with his kids: youtube.com/watch?v=PqZP6B… US Safety Info: bit.ly/48pSBk7

AbbottCardio's tweet image. Dennis doesn’t let #HeartFailure keep him from being a hands-on dad. Watch his story to see how our #HeartMate3 LVAD helps him show up (and keep up) with his kids: youtube.com/watch?v=PqZP6B… 

US Safety Info: bit.ly/48pSBk7

Lisa DePillo reposted

We’re excited to sponsor this #AAHFN2024 pre-meeting workshop for #HeartFailure nurses in partnership with @AAHFN and @VADCoordinator. Register to learn about MCS patient profiles, gain hands-on experience with percutaneous and durable options, and more: aahfnannualmeeting.org

AbbottCardio's tweet image. We’re excited to sponsor this #AAHFN2024 pre-meeting workshop for #HeartFailure nurses in partnership with @AAHFN and @VADCoordinator.

Register to learn about MCS patient profiles, gain hands-on experience with percutaneous and durable options, and more: aahfnannualmeeting.org

Lisa DePillo reposted

Share this webinar series designed to help people living with #HeartFailure better understand their condition and how our advanced #MedTech solutions may help improve their quality of life: domoreforheartfailure.com/webinars US Safety Info: bit.ly/47ZqOGP bit.ly/3usCWlN

AbbottCardio's tweet image. Share this webinar series designed to help people living with #HeartFailure better understand their condition and how our advanced #MedTech solutions may help improve their quality of life: domoreforheartfailure.com/webinars 

US Safety Info: bit.ly/47ZqOGP

bit.ly/3usCWlN

Lisa DePillo reposted

Join us at #ISHLT2024 to learn how we can transform #CardiovascularCare by challenging conventional LVAD practices, bridging the gender gap, and expanding access to #LVAD therapy. Register today: cvent.me/yPddNZ US Safety Info: bit.ly/3UY4me7


Lisa DePillo reposted

The @DIADetroit has been named the #1 Art Museum in the US as voted by @USATODAY for a 2nd year in a row! 🖼🏆🏆 With 65,000+ works and 100 galleries, the @diadetroit is a breathtaking Beaux-Arts museum and iconic Detroit attraction worth returning to again and again.


Amazing group of strong women!

In this JCF Ignite 🔥 piece, the authors explore novel interventions aimed at treating cardiorenal syndrome & achieving decongestion: ❓Which patients will benefit from renal pushers vs puller devices? ❓How do we measure success w/ these novel devices? 🔗bit.ly/4hHHKYn

JCardFail's tweet image. In this JCF Ignite 🔥 piece, the authors explore novel interventions aimed at treating cardiorenal syndrome & achieving decongestion:
❓Which patients will benefit from renal pushers vs puller devices?
❓How do we measure success w/ these novel devices? 
🔗bit.ly/4hHHKYn


Lisa DePillo reposted

Thank you to everyone who helped make #THT2024 the best one yet! 🫀 We’re inspired by your commitment to helping improve care and outcomes for people suffering from #HeartFailure. #CardioTwitter #CardioX

AbbottCardio's tweet image. Thank you to everyone who helped make #THT2024 the best one yet! 🫀 

We’re inspired by your commitment to helping improve care and outcomes for people suffering from #HeartFailure.

#CardioTwitter #CardioX
AbbottCardio's tweet image. Thank you to everyone who helped make #THT2024 the best one yet! 🫀 

We’re inspired by your commitment to helping improve care and outcomes for people suffering from #HeartFailure.

#CardioTwitter #CardioX
AbbottCardio's tweet image. Thank you to everyone who helped make #THT2024 the best one yet! 🫀 

We’re inspired by your commitment to helping improve care and outcomes for people suffering from #HeartFailure.

#CardioTwitter #CardioX
AbbottCardio's tweet image. Thank you to everyone who helped make #THT2024 the best one yet! 🫀 

We’re inspired by your commitment to helping improve care and outcomes for people suffering from #HeartFailure.

#CardioTwitter #CardioX

Lisa DePillo reposted

How do you measure a decade of progress? Join us for lunch at #THT2024 to discuss the future of heart failure therapies with our #HeartMate 3 LVAD and #CardioMEMS HF System: tht2024.crfconnect.com US Safety Info: bit.ly/4c0FGHS bit.ly/42LyFqq

AbbottCardio's tweet image. How do you measure a decade of progress?

Join us for lunch at #THT2024 to discuss the future of heart failure therapies with our #HeartMate 3 LVAD and #CardioMEMS HF System: tht2024.crfconnect.com 

US Safety Info:
bit.ly/4c0FGHS
bit.ly/42LyFqq

Lisa DePillo reposted

Don’t miss “Between Two Ventricles” with Dr. Philip Adamson – recording LIVE from #THT2024.🎙️⏺️ Stop by the podcast booth in the exhibit area to hear the latest insights before they hit the airwaves! Subscribe: bit.ly/42WId1P US Safety Info: bit.ly/3UXWXvA

AbbottCardio's tweet image. Don’t miss “Between Two Ventricles” with Dr. Philip Adamson – recording LIVE from #THT2024.🎙️⏺️

Stop by the podcast booth in the exhibit area to hear the latest insights before they hit the airwaves!

Subscribe: bit.ly/42WId1P 

US Safety Info: bit.ly/3UXWXvA

Lisa DePillo reposted

Q: What are the real-world, long-term clinical outcomes after HeartMate 3 LVAD implantation for #heartfailure? A: In a real-world registry of patients with HeartMate 3 LVADs, 5-year survival was 63.3%. This is comparable to clinical trial data. bit.ly/4bZdTHS #cvSurg


Lisa DePillo reposted

Share this webinar series designed to help people living with #HeartFailure better understand their condition and how our advanced #MedTech solutions may help improve their quality of life: domoreforheartfailure.com/webinars US Safety Info: bit.ly/47ZqOGP bit.ly/3usCWlN

AbbottCardio's tweet image. Share this webinar series designed to help people living with #HeartFailure better understand their condition and how our advanced #MedTech solutions may help improve their quality of life: domoreforheartfailure.com/webinars 

US Safety Info:
bit.ly/47ZqOGP 
bit.ly/3usCWlN

Lisa DePillo reposted

Expand your #PatientCare skills in our upcoming #LVAD webinar. You’ll gain expert best practices from @JonGrinsteinMD as he walks through complex clinical scenarios and answers your questions. US Safety Info: bit.ly/3rX062x


Lisa DePillo reposted

New #JACC Scientific Statement! Contemporary durable mechanical circulatory support improves survival, #QoL and functional capacity but is underutilized in the treatment of advanced #heartfailure. Read more from this crucial work: bit.ly/3t9eDIA #CardioTwitter #LVAD

JACCJournals's tweet image. New #JACC Scientific Statement!

Contemporary durable mechanical circulatory support improves survival, #QoL and functional capacity but is underutilized in the treatment of advanced #heartfailure.

Read more from this crucial work: bit.ly/3t9eDIA #CardioTwitter #LVAD

This will be good!

Aspire to improve #PatientOutcomes! 30 #LVAD centers, representing a variety of outcomes, were blindly selected to be surveyed to determine clinical behaviors and best practices used to support excellence in care for every patient. Excited to share our findings with you soon.



Lisa DePillo reposted

Always fun to end a workout with a little “freestyle” Mike Depillo - University of Buffalo Eli McLean - Wayne State University @bigmike_02 @elijahh_mclean #QBYOU


Lisa DePillo reposted

Please join us on May 6th for the MKE Annual Heart Failure Symposium. We have an impressive agenda. Our keynote speaker, Dr Mohiuddin will be discussing xenotransplantation. Looking forward to an in-person meeting to promote heart failure education, innovation and collaboration.

NSulemanjee's tweet image. Please join us on May 6th for the MKE Annual Heart Failure Symposium. We have an impressive agenda. Our keynote speaker, Dr Mohiuddin will be discussing xenotransplantation. Looking forward to an in-person meeting to promote heart failure education, innovation and collaboration.

A great conversation about giving patients choices!

Is it time to redefine your response for patients living with advanced #HeartFailure? Listen as Drs. Philip Adamson & Jennifer Cowger discuss the importance of #LVAD education, collaborative care & more on the latest episode of “Between Two Ventricles” – open.spotify.com/episode/36oBGJ…

AbbottCardio's tweet image. Is it time to redefine your response for patients living with advanced #HeartFailure? 

Listen as Drs. Philip Adamson & Jennifer Cowger discuss the importance of #LVAD education, collaborative care & more on the latest episode of “Between Two Ventricles” –
open.spotify.com/episode/36oBGJ…


Loading...

Something went wrong.


Something went wrong.